Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
bullish
Alibaba Health Information Tec
Watchlist
China Healthcare: Macro Themes
Equity Bottom-Up
526 Views
18 Dec 2020 12:56
This Insight summarizes the takeaways from a recent China healthcare industry conference. There is much talk of pressures on the industry, but innovative companies will benefit from policy tailwinds.
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 11-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Loading
Trending Insights
More »
NTT (9432) To Overpay To Take Over NTT Data (9613) Subsidiary?
Laopu Gold (6181 HK): US$300m Primary Placement & Index Inclusion Green Light
CATL (300750 CH): Index Inclusion as Potential Listing Nears
Swire Pac (19 HK): Thai Beverage Spin-Off
Don't Swim Naked: TIME TO PUT YOUR SHORTS ON!
Top Unpaywalled Insights
More »
Loading
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
BeiGene: Novartis Grabs Tislelizumab Rights
12 Jan 2021
BeiGene: Cancer Treatment in China--The Underestimated Opportunity
09 Jan 2021
Microport Cardioflow: Winning in TAVR
09 Jan 2021
China Healthcare: Macro Themes
18 Dec 2020
Eddingpharm: First Impressions
15 Dec 2020
Jacobio: Updated Valuation and Other Thoughts
04 Dec 2020
Asian Healthcare - Coming of Age
26 Nov 2020
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.3
x